These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 10221418)

  • 1. Treatment protocol determines the efficacy of clindamycin in acute murine toxoplasmosis.
    Nikolić T; Djurković-Djaković O; Bobić B; Nikolić A; Babić D
    Int J Antimicrob Agents; 1999 Feb; 11(2):145-9. PubMed ID: 10221418
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synergistic effect of clindamycin and atovaquone in acute murine toxoplasmosis.
    Djurković-Djaković O; Nikolić T; Robert-Gangneux F; Bobić B; Nikolić A
    Antimicrob Agents Chemother; 1999 Sep; 43(9):2240-4. PubMed ID: 10471572
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of atovaquone combined with clindamycin against murine infection with a cystogenic (Me49) strain of Toxoplasma gondii.
    Djurković-Djaković O; Milenković V; Nikolić A; Bobić B; Grujić J
    J Antimicrob Chemother; 2002 Dec; 50(6):981-7. PubMed ID: 12461021
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of clindamycin in a model of acute murine toxoplasmosis.
    Vuković D; Djurković-Djaković O; Kovacević S; Bobić B; Nikolić A; Todorović V; Babić D
    Clin Microbiol Infect; 1997 Feb; 3(1):89-94. PubMed ID: 11864081
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of ketolides in combination with other drugs to treat experimental toxoplasmosis.
    Araujo FG; Khan AA; Bryskier A; Remington JS
    J Antimicrob Chemother; 1998 Nov; 42(5):665-7. PubMed ID: 9848454
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Comparative activity of several antibiotics against Toxoplasma gondii in a mouse model].
    Rodríguez-Díaz JC; Martínez-Grueiro MM; Martínez-Fernández AR
    Enferm Infecc Microbiol Clin; 1993 Dec; 11(10):543-6. PubMed ID: 8142504
    [TBL] [Abstract][Full Text] [Related]  

  • 7. USE OF CLINDAMYCIN IN PALLAS' CATS [
    Girling SJ; Pizzi R; Naylor AD; Richardson D; Richardson U; Harley J; Cole G; Brown D; Fraser M; Tillman E; Barclay D
    J Zoo Wildl Med; 2020 Mar; 51(1):39-45. PubMed ID: 32212544
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment with interleukin 12 in combination with atovaquone or clindamycin significantly increases survival of mice with acute toxoplasmosis.
    Araujo FG; Hunter CA; Remington JS
    Antimicrob Agents Chemother; 1997 Jan; 41(1):188-90. PubMed ID: 8980778
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effects of clindamycin and josamycin in experimental Toxoplasma gondii infections].
    Terragna A; Canessa A; Terragna FM; Corradino L
    Minerva Med; 1984 Oct; 75(39):2305-8. PubMed ID: 6504394
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effectiveness of spiramycin in murine models of acute and chronic toxoplasmosis.
    Grujić J; Djurković-Djaković O; Nikolić A; Klun I; Bobić B
    Int J Antimicrob Agents; 2005 Mar; 25(3):226-30. PubMed ID: 15737517
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prophylactic efficacy of recombinant IL-12, clindamycin alone or in combination against experimental reactivated toxoplasmosis.
    Tawfeek GM; Oteifa NM; Mustafa MA
    J Egypt Soc Parasitol; 2001 Dec; 31(3):853-66. PubMed ID: 11775111
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of azithromycin in a murine toxoplasmosis model, employing a Toxoplasma gondii strain from Turkey.
    Değerli K; Kilimcioğlu AA; Kurt O; Tamay AT; Ozbilgin A
    Acta Trop; 2003 Sep; 88(1):45-50. PubMed ID: 12943976
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of clindamycin on acute and chronic toxoplasmosis in mice.
    Araujo FG; Remington JS
    Antimicrob Agents Chemother; 1974 Jun; 5(6):647-51. PubMed ID: 15825419
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of clindamycin on pneumonia from reactivation of Toxoplasma gondii infection in mice.
    Filice GA; Pomeroy C
    Antimicrob Agents Chemother; 1991 Apr; 35(4):780-2. PubMed ID: 2069389
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activity of gamma interferon in combination with pyrimethamine or clindamycin in treatment of murine toxoplasmosis.
    Israelski D; Remington J
    Eur J Clin Microbiol Infect Dis; 1990 May; 9(5):358-60. PubMed ID: 2115442
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nifurtimox plus pyrimethamine for treatment of murine toxoplasmosis.
    Aguirre-Cruz L; Velasco O; Sotelo J
    J Parasitol; 1998 Oct; 84(5):1032-3. PubMed ID: 9794648
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of antimicrobial agents on replication and stage conversion of Toxoplasma gondii.
    Gross U; Pohl F
    Curr Top Microbiol Immunol; 1996; 219():235-45. PubMed ID: 8791704
    [No Abstract]   [Full Text] [Related]  

  • 18. Successful treatment of acute experimental toxoplasmosis by spiramycin-loaded chitosan nanoparticles.
    Hagras NA; Allam AF; Farag HF; Osman MM; Shalaby TI; Fawzy Hussein Mogahed NM; Tolba MM; Shehab AY
    Exp Parasitol; 2019 Sep; 204():107717. PubMed ID: 31228418
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Triclosan and triclosan-loaded liposomal nanoparticles in the treatment of acute experimental toxoplasmosis.
    El-Zawawy LA; El-Said D; Mossallam SF; Ramadan HS; Younis SS
    Exp Parasitol; 2015 Feb; 149():54-64. PubMed ID: 25499511
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activity of minocycline against Toxoplasma gondii infection in mice.
    Chang HR; Comte R; Piguet PF; Pechère JC
    J Antimicrob Chemother; 1991 May; 27(5):639-45. PubMed ID: 1885421
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.